PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-16 4:29 pm Sale |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
PRICE T ROWE ASSOCIATES INC | 1,444,950 2.500% |
-9,424,610 (-86.71%) |
Filing |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
PRICE T ROWE ASSOCIATES INC | 10,869,560 2.500% |
7,159,719 (+192.99%) |
Filing |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Ascendis Pharma A/S ASND |
PRICE T ROWE ASSOCIATES INC | 3,709,841 6.500% |
-1,051,352 (-22.08%) |
Filing |
| 2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | Ascendis Pharma A/S ASND |
PRICE T ROWE ASSOCIATES INC | 4,761,193 8.300% |
-1,857,849 (-28.07%) |
Filing |
| 2021-02-16 12:23 pm Sale |
2020-12-31 | 13G | Ascendis Pharma A/S ASND |
PRICE T ROWE ASSOCIATES INC | 6,619,042 12.300% |
-1,142,254 (-14.72%) |
Filing |